Agilent Technologies R&D Spending Growth & History (A)
Agilent Technologies's r&d spending was $455.0M for fiscal 2025.
View full Agilent Technologies company overviewAgilent Technologies annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-10-31 | $455.0M | −$24.0M | −5.01% |
| 2024 | 2024-10-31 | $479.0M | −$2.0M | −0.42% |
| 2023 | 2023-10-31 | $481.0M | $14.0M | +3.00% |
| 2022 | 2022-10-31 | $467.0M | $26.0M | +5.90% |
| 2021 | 2021-10-31 | $441.0M | −$54.0M | −10.91% |
| 2020 | 2020-10-31 | $495.0M | $91.0M | +22.52% |
| 2019 | 2019-10-31 | $404.0M | $17.0M | +4.39% |
| 2018 | 2018-10-31 | $387.0M | $46.0M | +13.49% |
| 2017 | 2017-10-31 | $341.0M | $12.0M | +3.65% |
| 2016 | 2016-10-31 | $329.0M | −$1.0M | −0.30% |
| 2015 | 2015-10-31 | $330.0M | −$28.0M | −7.82% |
| 2014 | 2014-10-31 | $358.0M | $21.0M | +6.23% |
| 2013 | 2013-10-31 | $337.0M | −$331.0M | −49.55% |
| 2012 | 2012-10-31 | $668.0M | $19.0M | +2.93% |
| 2011 | 2011-10-31 | $649.0M | $37.0M | +6.05% |
| 2010 | 2010-10-31 | $612.0M | −$30.0M | −4.67% |
| 2009 | 2009-10-31 | $642.0M | −$62.0M | −8.81% |
| 2008 | 2008-10-31 | $704.0M | $19.0M | +2.77% |
| 2007 | 2007-10-31 | $685.0M | $30.0M | +4.58% |
| 2006 | 2006-10-31 | $655.0M | $5.0M | +0.77% |
| 2005 | 2005-10-31 | $650.0M | $51.0M | +8.51% |
| 2004 | 2004-10-31 | $599.0M | −$452.0M | −43.01% |
| 2003 | 2003-10-31 | $1.05B | −$199.0M | −15.92% |
| 2002 | 2002-10-31 | $1.25B | −$30.0M | −2.34% |
| 2001 | 2001-10-31 | $1.28B | $215.0M | +20.19% |
| 2000 | 2000-10-31 | $1.06B | — | — |
Agilent Technologies quarterly r&d spending
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-07-31 | $123.0M | $12.0M | +10.81% |
| Q2 2026 | 2026-04-30 | $126.0M | $14.0M | +12.50% |
| Q1 2026 | 2026-01-31 | $117.0M | $4.0M | +3.54% |
| Q4 2025 | 2025-10-31 | $119.0M | $8.0M | +7.21% |
| Q3 2025 | 2025-07-31 | $111.0M | −$16.0M | −12.60% |
| Q2 2025 | 2025-04-30 | $112.0M | −$1.0M | −0.88% |
| Q1 2025 | 2025-01-31 | $113.0M | −$15.0M | −11.72% |
| Q4 2024 | 2024-10-31 | $111.0M | −$3.0M | −2.63% |
| Q3 2024 | 2024-07-31 | $127.0M | $9.0M | +7.63% |
| Q2 2024 | 2024-04-30 | $113.0M | −$13.0M | −10.32% |
| Q1 2024 | 2024-01-31 | $128.0M | $5.0M | +4.07% |
| Q4 2023 | 2023-10-31 | $114.0M | −$5.0M | −4.20% |
| Q3 2023 | 2023-07-31 | $118.0M | $2.0M | +1.72% |
| Q2 2023 | 2023-04-30 | $126.0M | $11.0M | +9.57% |
| Q1 2023 | 2023-01-31 | $123.0M | $6.0M | +5.13% |
| Q4 2022 | 2022-10-31 | $119.0M | $3.0M | +2.59% |
| Q3 2022 | 2022-07-31 | $116.0M | $3.0M | +2.65% |
| Q2 2022 | 2022-04-30 | $115.0M | $6.0M | +5.50% |
| Q1 2022 | 2022-01-31 | $117.0M | $14.0M | +13.59% |
| Q4 2021 | 2021-10-31 | $116.0M | $14.0M | +13.73% |
| Q3 2021 | 2021-07-31 | $113.0M | $21.0M | +22.83% |
| Q2 2021 | 2021-04-30 | $109.0M | −$88.0M | −44.67% |
| Q1 2021 | 2021-01-31 | $103.0M | −$1.0M | −0.96% |
| Q4 2020 | 2020-10-31 | $102.0M | $0 | 0.00% |
| Q3 2020 | 2020-07-31 | $92.0M | −$9.0M | −8.91% |
| Q2 2020 | 2020-04-30 | $197.0M | $98.0M | +98.99% |
| Q1 2020 | 2020-01-31 | $104.0M | $2.0M | +1.96% |
| Q4 2019 | 2019-10-31 | $102.0M | −$2.0M | −1.92% |
| Q3 2019 | 2019-07-31 | $101.0M | $4.0M | +4.12% |
| Q2 2019 | 2019-04-30 | $99.0M | $7.0M | +7.61% |
| Q1 2019 | 2019-01-31 | $102.0M | $8.0M | +8.51% |
| Q4 2018 | 2018-10-31 | $104.0M | $13.0M | +14.29% |
| Q3 2018 | 2018-07-31 | $97.0M | $10.0M | +11.49% |
| Q2 2018 | 2018-04-30 | $92.0M | $8.0M | +9.52% |
| Q1 2018 | 2018-01-31 | $94.0M | $15.0M | +18.99% |
| Q4 2017 | 2017-10-31 | $91.0M | $7.0M | +8.33% |
| Q3 2017 | 2017-07-31 | $87.0M | $1.0M | +1.16% |
| Q2 2017 | 2017-04-30 | $84.0M | $3.0M | +3.70% |
| Q1 2017 | 2017-01-31 | $79.0M | $1.0M | +1.28% |
| Q4 2016 | 2016-10-31 | $84.0M | $2.0M | +2.44% |
| Q3 2016 | 2016-07-31 | $86.0M | $7.0M | +8.86% |
| Q2 2016 | 2016-04-30 | $81.0M | $0 | 0.00% |
| Q1 2016 | 2016-01-31 | $78.0M | −$10.0M | −11.36% |
| Q4 2015 | 2015-10-31 | $82.0M | −$15.0M | −15.46% |
| Q3 2015 | 2015-07-31 | $79.0M | −$7.0M | −8.14% |
| Q2 2015 | 2015-04-30 | $81.0M | −$6.0M | −6.90% |
| Q1 2015 | 2015-01-31 | $88.0M | $0 | 0.00% |
| Q4 2014 | 2014-10-31 | $97.0M | — | — |
| Q3 2014 | 2014-07-31 | $86.0M | −$85.0M | −49.71% |
| Q2 2014 | 2014-04-30 | $87.0M | −$94.0M | −51.93% |
| Q1 2014 | 2014-01-31 | $88.0M | −$91.0M | −50.84% |
| Q3 2013 | 2013-07-31 | $171.0M | $9.0M | +5.56% |
| Q2 2013 | 2013-04-30 | $181.0M | $15.0M | +9.04% |
| Q1 2013 | 2013-01-31 | $179.0M | $17.0M | +10.49% |
| Q4 2012 | 2012-10-31 | $178.0M | $15.0M | +9.20% |
| Q3 2012 | 2012-07-31 | $162.0M | $0 | 0.00% |
| Q2 2012 | 2012-04-30 | $166.0M | $1.0M | +0.61% |
| Q1 2012 | 2012-01-31 | $162.0M | $3.0M | +1.89% |
| Q4 2011 | 2011-10-31 | $163.0M | $4.0M | +2.52% |
| Q3 2011 | 2011-07-31 | $162.0M | $8.0M | +5.19% |
| Q2 2011 | 2011-04-30 | $165.0M | $15.0M | +10.00% |
| Q1 2011 | 2011-01-31 | $159.0M | $10.0M | +6.71% |
| Q4 2010 | 2010-10-31 | $159.0M | $9.0M | +6.00% |
| Q3 2010 | 2010-07-31 | $154.0M | $1.0M | +0.65% |
| Q2 2010 | 2010-04-30 | $150.0M | −$20.0M | −11.76% |
| Q1 2010 | 2010-01-31 | $149.0M | −$20.0M | −11.83% |
| Q4 2009 | 2009-10-31 | $150.0M | — | — |
| Q3 2009 | 2009-07-31 | $153.0M | −$17.0M | −10.00% |
| Q2 2009 | 2009-04-30 | $170.0M | — | — |
| Q1 2009 | 2009-01-31 | $169.0M | — | — |
| Q3 2008 | 2008-07-31 | $170.0M | — | — |
Agilent Technologies r&d spending trends
Over the last five fiscal years, Agilent Technologies's r&d spending decreased from $495.0M to $455.0M, a change of −$40.0M. The latest reported quarter, Q3 2026, shows $123.0M.
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Agilent Technologies source filings ↗